Provided by Tiger Trade Technology Pte. Ltd.

EDDING GENOR

1.745
-0.025-1.41%
Volume:1.12M
Turnover:1.94M
Market Cap:3.47B
PE:7.43
High:1.750
Open:1.745
Low:1.690
Close:1.770
52wk High:5.150
52wk Low:1.420
Shares:1.99B
HK Float Shares:1.99B
Volume Ratio:3.08
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.235
ROE:6.70%
ROA:4.71%
PB:0.75
PE(LYR):7.43
PS:1.34

Loading ...

Edding Genor repurchases 0.20 million shares for HK$0.40 million, treasury stock rises to 24.15 million

Bulletin Express
·
Jul 16

Edding Genor Group Files HKEX Next-day Return Disclosing Share Repurchase

Reuters
·
Jul 16

Edding Genor buys back 38,000 shares; outstanding share count edges down to 1.99 billion

Bulletin Express
·
Jul 15

EDDING GENOR repurchases 0.20 million shares, marginally reducing issued float

Bulletin Express
·
Jul 14

Edding Genor Group Files HKEX Next-day Disclosure Return After Share Repurchase

Reuters
·
Jul 14

Edding Genor repurchases 200,000 shares for HK$0.38 million, outstanding free-float slips 0.01%

Bulletin Express
·
Jul 13

EDDING GENOR Allocates HK$384,800 for Share Buyback on July 13

Stock News
·
Jul 13

Edding Genor executes on-market buyback of 0.02 million shares, treasury stock rises to 23.51 million

Bulletin Express
·
Jul 10

EDDING GENOR Allocates HK$359,500 for Share Buyback on July 9

Stock News
·
Jul 09

Edding Genor Group Files HKEX Next-day Disclosure Return Reporting Share Repurchase

Reuters
·
Jul 09

Edding Genor Authorises On-Market Repurchase of Up to 10% of Issued Shares Ahead of 2027 AGM

Bulletin Express
·
Jul 07

EDDING GENOR Announces Share Buyback Initiative

Stock News
·
Jul 07

Edding Genor Group Plans On-market Share Buyback of up to 10% Under Mandate

Reuters
·
Jul 07

Genor Biopharma Receives China Nod for Breast Cancer Drug Trial

MT Newswires Live
·
Jul 03

Edding Genor Climbs on Approval of Clinical Trial of Cancer Drug in China

Reuters
·
Jul 03

JHBP Cy's Phase Ib/ii Clinical Trial of Gb268 Obtains IND Approval by NMPA

Reuters
·
Jul 03

Edding Genor Receives NMPA Approval for Phase Ib/II Clinical Trial of GB268

Stock News
·
Jul 02

Jhbp Cy - Phase Ib/ii Clinical Trial of Gb268 Obtains Ind Approval by Nmpa

THOMSON REUTERS
·
Jul 02

Edding Genor AGM: All Resolutions Secure at Least 99.79% Support, Renewing Board Mandates and 10% Buy-back Authority

Bulletin Express
·
Jun 26

Chief Executive Officer & Executive Chairman of Edding Genor Group Holdings Xin Ni Buys More Stock

Simply Wall St.
·
Jun 17